The Influence of Donor and Recipient Complement C3 Polymorphisms on Liver Transplant Outcome

Area of Science:

• Transplantation immunology
• Genetics
• Complement system biology

Background:

• Conflicting evidence exists regarding the impact of complement C3 polymorphism on liver transplant outcomes.
• Understanding the influence of donor and recipient C3 genotype is crucial for improving post-transplant results.

Purpose of the Study:

• To clarify the independent and combined effects of donor and recipient C3 genotype on liver transplant patient and graft survival.
• To assess the impact of C3 genotype on acute rejection incidence.
• To evaluate the influence of donor type (brain death vs. circulatory death) on these outcomes.

Main Methods:

• Analysis of eight donor/recipient C3 genotype groups (based on F allele presence/absence) in 506 liver transplant recipients.
• Correlation of genotypes with clinical outcomes: patient survival, graft survival, and acute rejection.
• Cox proportional hazards analysis to determine independent predictors of outcomes, including donor type.

Main Results:

• Five-year patient and graft survival rates were 90% and 77%, respectively, with 72% rejection-free.
• Donor C3 F variant, especially from brain-death donors, was associated with worse patient survival.
• Recipient C3 genotype independently predicted graft survival, and donor C3 F variant correlated with poorer graft survival, particularly in brain-death donors. Acute rejection significantly impacted patient survival, and donor type influenced rejection incidence.

Conclusions:

• Both donor and recipient complement C3 genotype play a role in liver transplant outcomes.
• Donor type (circulatory death vs. brain death) is an additional influential factor, potentially mediated by the inflammatory environment.
• Further research into the mechanisms underlying C3 genotype and donor type effects is warranted.